pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-605 |
Genomic Coordinates | chr10: 51299573 - 51299655 |
Synonyms | MIRN605, hsa-mir-605, MIR605 |
Description | Homo sapiens miR-605 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-605-5p | ||||||||||||||||||||||||||||||||||||
Sequence | 16| UAAAUCCCAUGGUGCCUUCUCCU |38 | ||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||
Experiments | SAGE | ||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SEC24D | ||||||||||||||||||||
Synonyms | CLCRP2 | ||||||||||||||||||||
Description | SEC24 homolog D, COPII coat complex component | ||||||||||||||||||||
Transcript | NM_014822 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SEC24D | |||||||||||||||||||||
3'UTR of SEC24D (miRNA target sites are highlighted) |
>SEC24D|NM_014822|3'UTR 1 TTGAAACTTCTCTGTCATTGATGTTGCATTTCCAAGGAGATAATCTCCTTCTTGGTGCCTAATTTTCTAGATGATAATAG 81 GCTAGTTTTGATTTCTTGCTCATTTTCAGAATAACTTTCCAGGAAGAGATGGCATTTAGAACTTCAGCTTTGGTGCTCAG 161 GTATAAAGCCAATTAAGGTACAATTGTACCATAAAGGGAACAATCTGTTTCTGATTGCACAGTTTCTAATTTTTAAAACT 241 GATGTGGTTTGCATTTCATAAAAGGCAAAGTTTACAGAACCATAAACATTCTCAATTTTCTTTATGCTAGACATATAAAT 321 TATTTTTCAAACTGTATAGATTTGGGGTAAAAAGTTGTCTCAGTTCCTCTCCCAATTGCAATGAGAAAAAAAAGCTTAAT 401 TTTTACATTATACTTAATTTTCTAAAACCATGTAACTCCATTGAACACATTTTTCAACTTAAGGTCTGCATAGCAGACTT 481 TTAATAACCTTGGGATTTATCTGGTAGAACAATATGTGTTCTACATTTTTTTCATAATTATATATTGTGTATGTTAAAAC 561 TATTTTCCAGTTGTTTTGTCTGTAAAACTGTCTTTATCAATATGCTTAATGGTTCTTTGTACAATTTTGAAAGTTTCTAC 641 CTGTATATAATGGATGTTAACCAGTATCAATAAATCACTTCGTATAATCTTAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HeLa , MCF-7 |
Disease | MIMAT0003273; |
Location of target site | 3'UTR, 5'UTR |
Tools used in this research | miBridge |
Original Description (Extracted from the article) |
...
"Induction of miR-605 reduced SEC24D mRNA and pro-tein levels
... - Lee I; Ajay SS; Yook JI; Kim HS; Hong SH; et al., 2009, Genome research. |
Article |
- Lee I; Ajay SS; Yook JI; Kim HS; Hong SH; et al. - Genome research, 2009
MicroRNAs (miRNAs) are known to post-transcriptionally regulate target mRNAs through the 3'-UTR, which interacts mainly with the 5'-end of miRNA in animals. Here we identify many endogenous motifs within human 5'-UTRs specific to the 3'-ends of miRNAs. The 3'-end of conserved miRNAs in particular has significant interaction sites in the human-enriched, less conserved 5'-UTR miRNA motifs, while human-specific miRNAs have significant interaction sites only in the conserved 5'-UTR motifs, implying both miRNA and 5'-UTR are actively evolving in response to each other. Additionally, many miRNAs with their 3'-end interaction sites in the 5'-UTRs turn out to simultaneously contain 5'-end interaction sites in the 3'-UTRs. Based on these findings we demonstrate combinatory interactions between a single miRNA and both end regions of an mRNA using model systems. We further show that genes exhibiting large-scale protein changes due to miRNA overexpression or deletion contain both UTR interaction sites predicted. We provide the predicted targets of this new miRNA target class, miBridge, as an efficient way to screen potential targets, especially for nonconserved miRNAs, since the target search space is reduced by an order of magnitude compared with the 3'-UTR alone. Efficacy is confirmed by showing SEC24D regulation with hsa-miR-605, a miRNA identified only in primate, opening the door to the study of nonconserved miRNAs. Finally, miRNAs (and associated proteins) involved in this new targeting class may prevent 40S ribosome scanning through the 5'-UTR and keep it from reaching the start-codon, preventing 60S association.
LinkOut: [PMID: 19336450]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
107 hsa-miR-605-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT001230 | SEC24D | SEC24 homolog D, COPII coat complex component | 3 | 1 | ||||||||
MIRT016155 | TP53 | tumor protein p53 | 2 | 1 | ||||||||
MIRT016156 | TCEAL1 | transcription elongation factor A like 1 | 1 | 1 | ||||||||
MIRT016157 | MDM2 | MDM2 proto-oncogene | 2 | 1 | ||||||||
MIRT040476 | YBX1 | Y-box binding protein 1 | 1 | 1 | ||||||||
MIRT040477 | TMEM64 | transmembrane protein 64 | 1 | 1 | ||||||||
MIRT040478 | KDM5C | lysine demethylase 5C | 1 | 1 | ||||||||
MIRT040479 | TRAF4 | TNF receptor associated factor 4 | 1 | 1 | ||||||||
MIRT040480 | DRG1 | developmentally regulated GTP binding protein 1 | 1 | 1 | ||||||||
MIRT040481 | BCL9 | B-cell CLL/lymphoma 9 | 1 | 1 | ||||||||
MIRT055125 | SCD | stearoyl-CoA desaturase | 2 | 2 | ||||||||
MIRT057521 | CEP55 | centrosomal protein 55 | 2 | 2 | ||||||||
MIRT081129 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT096817 | ZSWIM6 | zinc finger SWIM-type containing 6 | 2 | 4 | ||||||||
MIRT100961 | CENPQ | centromere protein Q | 2 | 4 | ||||||||
MIRT263338 | ANAPC16 | anaphase promoting complex subunit 16 | 2 | 2 | ||||||||
MIRT274710 | CPSF6 | cleavage and polyadenylation specific factor 6 | 2 | 2 | ||||||||
MIRT311193 | ANKRD33B | ankyrin repeat domain 33B | 2 | 2 | ||||||||
MIRT360127 | DEK | DEK proto-oncogene | 2 | 2 | ||||||||
MIRT438269 | PSMD10 | proteasome 26S subunit, non-ATPase 10 | 2 | 1 | ||||||||
MIRT442464 | SLC25A13 | solute carrier family 25 member 13 | 2 | 2 | ||||||||
MIRT446110 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT463119 | ZNF507 | zinc finger protein 507 | 2 | 2 | ||||||||
MIRT470566 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT475059 | IVNS1ABP | influenza virus NS1A binding protein | 2 | 6 | ||||||||
MIRT482538 | ACTB | actin beta | 2 | 4 | ||||||||
MIRT494136 | DCAF7 | DDB1 and CUL4 associated factor 7 | 2 | 6 | ||||||||
MIRT495209 | EDN3 | endothelin 3 | 2 | 2 | ||||||||
MIRT495235 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT496762 | MANBAL | mannosidase beta like | 2 | 2 | ||||||||
MIRT498885 | ZNF12 | zinc finger protein 12 | 2 | 10 | ||||||||
MIRT499280 | NBPF11 | NBPF member 11 | 2 | 2 | ||||||||
MIRT507063 | H3F3B | H3 histone family member 3B | 2 | 2 | ||||||||
MIRT508352 | HES7 | hes family bHLH transcription factor 7 | 2 | 8 | ||||||||
MIRT510740 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT519872 | ZFP62 | ZFP62 zinc finger protein | 2 | 4 | ||||||||
MIRT521272 | RTN4 | reticulon 4 | 2 | 4 | ||||||||
MIRT522324 | NFIB | nuclear factor I B | 2 | 6 | ||||||||
MIRT525011 | ACTN4 | actinin alpha 4 | 2 | 6 | ||||||||
MIRT526608 | AASDH | aminoadipate-semialdehyde dehydrogenase | 2 | 4 | ||||||||
MIRT529043 | ARL9 | ADP ribosylation factor like GTPase 9 | 2 | 2 | ||||||||
MIRT529545 | ZNF678 | zinc finger protein 678 | 2 | 2 | ||||||||
MIRT532500 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT532599 | SIX4 | SIX homeobox 4 | 2 | 2 | ||||||||
MIRT534044 | STK4 | serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT534087 | SPPL3 | signal peptide peptidase like 3 | 2 | 2 | ||||||||
MIRT534249 | SLC16A1 | solute carrier family 16 member 1 | 2 | 2 | ||||||||
MIRT534286 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT534555 | RUNX1 | runt related transcription factor 1 | 2 | 2 | ||||||||
MIRT536765 | HOXB2 | homeobox B2 | 2 | 2 | ||||||||
MIRT537227 | GAN | gigaxonin | 2 | 2 | ||||||||
MIRT551105 | TTC8 | tetratricopeptide repeat domain 8 | 2 | 2 | ||||||||
MIRT552247 | DUSP3 | dual specificity phosphatase 3 | 2 | 2 | ||||||||
MIRT554361 | SFXN5 | sideroflexin 5 | 2 | 2 | ||||||||
MIRT557402 | H3F3C | H3 histone family member 3C | 2 | 2 | ||||||||
MIRT559116 | C16orf52 | chromosome 16 open reading frame 52 | 2 | 2 | ||||||||
MIRT560494 | BUB3 | BUB3, mitotic checkpoint protein | 2 | 2 | ||||||||
MIRT562296 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT562597 | CAPZA2 | capping actin protein of muscle Z-line alpha subunit 2 | 2 | 2 | ||||||||
MIRT563857 | ALYREF | Aly/REF export factor | 2 | 4 | ||||||||
MIRT565665 | SIX1 | SIX homeobox 1 | 2 | 2 | ||||||||
MIRT568253 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT609593 | GPM6B | glycoprotein M6B | 2 | 2 | ||||||||
MIRT611552 | GGT6 | gamma-glutamyltransferase 6 | 2 | 2 | ||||||||
MIRT613451 | CYLD | CYLD lysine 63 deubiquitinase | 2 | 2 | ||||||||
MIRT615516 | PRRC2A | proline rich coiled-coil 2A | 2 | 2 | ||||||||
MIRT617766 | C17orf105 | chromosome 17 open reading frame 105 | 2 | 2 | ||||||||
MIRT619134 | MCOLN3 | mucolipin 3 | 2 | 2 | ||||||||
MIRT621365 | CAP2 | cyclase associated actin cytoskeleton regulatory protein 2 | 2 | 2 | ||||||||
MIRT625804 | MDC1 | mediator of DNA damage checkpoint 1 | 2 | 2 | ||||||||
MIRT626954 | PRDM2 | PR/SET domain 2 | 2 | 2 | ||||||||
MIRT627716 | RCAN1 | regulator of calcineurin 1 | 2 | 2 | ||||||||
MIRT628069 | KCNJ13 | potassium voltage-gated channel subfamily J member 13 | 2 | 2 | ||||||||
MIRT630451 | GTPBP8 | GTP binding protein 8 (putative) | 2 | 2 | ||||||||
MIRT635533 | ELMOD2 | ELMO domain containing 2 | 2 | 2 | ||||||||
MIRT636206 | SULF2 | sulfatase 2 | 2 | 2 | ||||||||
MIRT638763 | EPHA4 | EPH receptor A4 | 2 | 2 | ||||||||
MIRT640324 | STAT1 | signal transducer and activator of transcription 1 | 2 | 2 | ||||||||
MIRT644548 | SPOP | speckle type BTB/POZ protein | 2 | 2 | ||||||||
MIRT645114 | TMX2 | thioredoxin related transmembrane protein 2 | 2 | 2 | ||||||||
MIRT647778 | NANOS1 | nanos C2HC-type zinc finger 1 | 2 | 2 | ||||||||
MIRT650112 | ZCCHC9 | zinc finger CCHC-type containing 9 | 2 | 2 | ||||||||
MIRT650136 | ABCB7 | ATP binding cassette subfamily B member 7 | 2 | 2 | ||||||||
MIRT650310 | SLC35E2 | solute carrier family 35 member E2 | 2 | 2 | ||||||||
MIRT650930 | ST6GALNAC1 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT651018 | ZNF740 | zinc finger protein 740 | 2 | 2 | ||||||||
MIRT653541 | SLC38A9 | solute carrier family 38 member 9 | 2 | 2 | ||||||||
MIRT655752 | NR2C2 | nuclear receptor subfamily 2 group C member 2 | 2 | 2 | ||||||||
MIRT656908 | KIAA1958 | KIAA1958 | 2 | 2 | ||||||||
MIRT657854 | GJD3 | gap junction protein delta 3 | 2 | 2 | ||||||||
MIRT658215 | FBXO21 | F-box protein 21 | 2 | 2 | ||||||||
MIRT659884 | CAPN7 | calpain 7 | 2 | 2 | ||||||||
MIRT659922 | CACNA1E | calcium voltage-gated channel subunit alpha1 E | 2 | 2 | ||||||||
MIRT660055 | C12orf5 | TP53 induced glycolysis regulatory phosphatase | 1 | 1 | ||||||||
MIRT664616 | LIMD1 | LIM domains containing 1 | 2 | 2 | ||||||||
MIRT665392 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT667887 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT669018 | CHORDC1 | cysteine and histidine rich domain containing 1 | 2 | 2 | ||||||||
MIRT688419 | DUSP2 | dual specificity phosphatase 2 | 2 | 2 | ||||||||
MIRT691888 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT709530 | GEN1 | GEN1, Holliday junction 5' flap endonuclease | 2 | 2 | ||||||||
MIRT711013 | ABCD2 | ATP binding cassette subfamily D member 2 | 2 | 2 | ||||||||
MIRT714731 | CENPH | centromere protein H | 2 | 2 | ||||||||
MIRT719897 | PTGIS | prostaglandin I2 synthase | 2 | 2 | ||||||||
MIRT725028 | CX3CL1 | C-X3-C motif chemokine ligand 1 | 2 | 2 | ||||||||
MIRT734348 | P2RY12 | purinergic receptor P2Y12 | 3 | 0 | ||||||||
MIRT736719 | TNFAIP3 | TNF alpha induced protein 3 | 3 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|